← SynDRA
THONZONIUM
SynDRA canonical compound SYN0023534 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | ATPase inhibitor |
|---|
| Indication | ear infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- APAF1
- SMAD3
- NFE2L2
- NR1I2
- PIN1
- RAPGEF3
- RNMT
- SAMHD1
- SMPD1
- ATAD5
- TARDBP
- TDP1
- TMPRSS15
- TSHR
- UBE2N
- USP1
- LMNA
- KDM4A
- IDH1
- HSP90AA1
- HDAC6
- GMNN
- GLS
- GBA1
- FEN1
- EYA2
- ENTPD5
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- ATXN2
- USP2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACES
- MDM4
- MRGPRX1
- NSD2
- NTM1A
- NTMT1
- NUDT15
- OPRD
- OPRM
- PA21B
- PAFA
- PPCEL
- PPP1CA
- PPP5C
- PSDE
- RARA
- SC5A7
- SSPN
- STK33
- SYK
- TP53
- TR10B
- UBP1
- UBP2
- UCHL5
- MITF
- MDM2
- ANDR
- KSYK
- APAF
- APLNR
- ATG4B
- CASP3
- CASP9
- CCR6
- CP19A
- CP2C9
- CP2D6
- CP3A7
- DRD3
Cross-references
Synonyms
- COLY-MYCIN S
- tonzonium
- thonzonium bromide
- tonzonium bromide
- thonzide
- Thonzonium cation
- Thonzonium ion
- Tonzonium
- Z05ZE98FV8
- NCGC00016507-01
- CAS-553-08-2
- UNII-Z05ZE98FV8
- Thonizide
- Prestwick0_000925
- Prestwick1_000925
- Prestwick2_000925
- Prestwick3_000925
- TONZONIUM [WHO-DD]
- BSPBio_000830
- cid_11102
- SPBio_003009
- BPBio1_000914
- SCHEMBL5990893
- CHEMBL1201322
- DTXSID8048232
- BDBM59083
- CHEBI:94514
- ZINC8035268
- DB09552
- NCGC00016507-02
- NCGC00016507-03
- AB00513967
- AB00513967_12
- AB00513967_13
- Q27166363
- Hexadecyl[2-[(p-methoxybenzyl)-2-pyrimidinylamino]ethyl]dimethylaminium
- RefChem:897992
Reported adverse events
Look up THONZONIUM in the interactive SynDRA portal →